Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02439437 · ClinicalTrials.gov registry record · NA

Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain

A NA study of Breast Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02439437: Completed NA study of Breast Cancer, sponsored by Duke University.

NCT02439437 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 28 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02439437, a NA study of Breast Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This study looks at whether a coping skills training program can help women manage pain and stress after breast surgery, and lower the risk of developing chronic pain. This coping skills program includes eight training sessions that are done by telephone. These sessions will focus on strategies for dealing with pain and stress, and how to apply these strategies to subjects' own experiences.

Primary Outcome

The investigators will use BCPQ (Brest Cancer Pain Questionnaire) questionnaire to record breast pain

Conditions Studied

Interventions

  • BEHAVIORAL Psychosocial Intervention

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2015-10-08
Est. Completion 2020-01-06
Phase NA
Duke University

1,725 total trials

What the finished NCT02439437 record still lists

NCT02439437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial Intervention is the first listed.

NCT02439437 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02439437 about?

NCT02439437 is a clinical study titled "Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain". This study looks at whether a coping skills training program can help women manage pain and stress after breast surgery, and lower the risk of developing chronic pain. This coping skills program includes eight training sessions that are done by telephone. These sessions will focus on strategies for ...

What is the current status of trial NCT02439437?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-10-08. Estimated completion is 2020-01-06.

What conditions does trial NCT02439437 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02439437?

The interventions under investigation include: Psychosocial Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02439437?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02439437 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02439437's enrollment target sits among peer trials

28 1005th of 1224 higher than 207 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02439437, the US trial registry maintained by the National Library of Medicine. NCT02439437 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.